Biocon Limited announced its participation in the Goldman Sachs India Pharma Corporate Days event. The interaction is scheduled to take place on March 6, 2026, and will be conducted virtually. The management team of Biocon Limited will engage in this event. The company has stated that no Unpublished Price Sensitive Information (UPSI) will be disclosed during these meetings. This schedule is subject to change based on exigencies from either the investors' or the company's side. The information regarding this event will also be made available on Biocon's official website, www.biocon.com.
